Journal Publications
Project Data Sphere's success is ultimately measured by the practice-changing scientific insights discovered by the research community. We are proud to share the following list of peer-accepted publications, and we are grateful to the data providers, research scientists, and patients that make this possible.
| Author(s) | Date |
Article Title |
Journal |
|---|---|---|---|
|
Amita Puranik, Prajakta Dandekar, Ratnesh Jain |
August 2022 | Exploring the potential of machine learning for more efficient development and production of biopharmaceuticals | AIChE Biotechnology Progress |
|
Xiang Yin, Pallavi S. Mishra-Kalyan, Rajeshwari Sridhara, Mark D. Stewart,Elizabeth A. Stuart, and Ruthanna C. Davi |
January 2022 | Exploring the Potential of External Control Arms created from Patient Level Data: A case study in non-small cell lung cancer | Journal of Biopharmaceutical Statistics |
|
Kelsey H Natsuhara, Li Zhang, Christopher A Carlos, Hala T Borno |
April 2021 | Evaluating predictors of renal injury with sorafenib in hepatocellular carcinoma: A multi-ethnic cohort study | Journal of Onco-Nephrology |
|
Julia Wilkerson, Kald Abdallah, Charles Hugh-Jones, Greg Curt, Mace Rothenberg, Ronit Simantov, Martin Murphy, Joseph Morrell, Joel Beetsch, Daniel J. Sargent, Howard I. Scher, Peter Lebowitz,, Richard Simon, Wilfred D. Stein, Susan E. Bates, Tito Fojo |
January 2017 | Estimation of Tumour Regression and Growth Rates During Treatment in Patients with Advanced Prostate Cancer: A Retrospective Analysis | The Lancet Oncology |
|
Julia Wilkerson, Kald Abdallah, Charles Hugh-Jones, Greg Curt, Mace Rothenberg, Ronit Simantov, Martin Murphy, Joseph Morrell, Joel Beetsch, Daniel J. Sargent, Howard I. Scher, Peter Lebowitz, Richard Simon, Wilfred D. Stein, Susan E. Bates, Tito Fojo |
December 2016 | Estimation of Tumour Regression and Growth Rates During Treatment in Patients with Advanced Prostate Cancer: A retrospective Analysis | Lancet Oncology |
|
Hiroyuki Saeki, Takuji Komeda, Risa Tanaka, Yuki Yamatani & Hironori Sakai |
March 2022 | Estimation of a Suitable Number of Patients for Selective Safety Data Collection (ICH E19 Draft Guideline): When is the Safety Profile of a Drug Well Characterized? | Therapeutic Innovation & Regulatory Science |
|
Teemu D. Laajala, Mika Murtojārvi, Arho Virkki, Tero Aittokalio |
June 2018 | ePCR: An R-package for Survival Time and Time-to-Event Prediction in Advanced Prostate Cancer, Applied to Real-World Patient Cohorts | Bioinformatics |
|
Steven B.Cohen, Jennifer Unangst, Feng Yu |
November 2020 | Enhancing the analytic utility of clinical trial data to inform health disparities research | Contemporary Clinical Trials Communications |
|
Omar Abdel-Rahman |
October 2019 | Efficacy and toxicity outcomes of elderly castrate-resistant prostate cancer patients treated with docetaxel - A pooled analysis of 3 randomized studies | Urologic Oncology: Seminars and Original Investigations |
|
Eric V.Li, Mohammad R.Siddiqui, Adam B.Weiner, Anna E.Prizment, Charles J.Ryan, Alicia K.Morgans |
March 2021 | Efficacy and adverse events of docetaxel for metastatic, hormone-sensitive prostate cancer among elderly men: post-hoc analysis of CHAARTED trial | Clinical Genitourinary Cancer |
|
Warit Ruanglertboon, Michael J. Sorich, Andrew Rowland, Ashley M. Hopkins |
May 2020 | Effect of early adverse events resulting in sorafenib dose adjustments on survival outcomes of advanced hepatocellular carcinoma patients | International Journal of Clinical Oncology |
|
Qiyu Wang, Ian A. Strohbehn, Sophia Zhao, Harish Seethapathy, Samuel D. Strohbehn, Paul Hanna, Meghan Lee, Riley Fadden, Ryan J. Sullivan, Genevieve M. Boland, Kerry L. Reynolds, Meghan E. Sise |
August 2022 | Effect of Cancer Stage on Adverse Kidney Outcomes in Patients Receiving Immune Checkpoint Inhibitors for Melanoma | ScienceDirect |
|
S. Peter Wu, Moses Tam, Raymond Mailhot Vega, Carmen A. Perez, Naamit Kurshan Gerber |
November 2017 | Effect of Breast Irradiation on Cardiac Disease in Women Enrolled in BCIRG-001 at 10-Year Follow-Up | Radiation Oncology |
|
Omar Abdel-Rahman |
December 2019 | Effect of Body Mass Index on 5-FU-Based Chemotherapy Toxicity and Efficacy Among Patients With Metastatic Colorectal Cancer; A Pooled Analysis of 5 Randomized Trials | Clinical Colorectal Cancer |
